<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
33261-658-30
</NDCCode>
<PackageDescription>
30 TABLET in 1 BOTTLE, PLASTIC (33261-658-30)
</PackageDescription>
<NDC11Code>
33261-0658-30
</NDC11Code>
<ProductNDC>
33261-658
</ProductNDC>
<ProductTypeName>
HUMAN PRESCRIPTION DRUG
</ProductTypeName>
<ProprietaryName>
Doxazosin
</ProprietaryName>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Doxazosin Mesylate
</NonProprietaryName>
<DosageFormName>
TABLET
</DosageFormName>
<RouteName>
ORAL
</RouteName>
<StartMarketingDate>
20111027
</StartMarketingDate>
<EndMarketingDate/>
<MarketingCategoryName>
ANDA
</MarketingCategoryName>
<ApplicationNumber>
ANDA075509
</ApplicationNumber>
<LabelerName>
Aidarex Pharmaceuticals LLC
</LabelerName>
<SubstanceName>
DOXAZOSIN MESYLATE
</SubstanceName>
<StrengthNumber>
4
</StrengthNumber>
<StrengthUnit>
mg/1
</StrengthUnit>
<Pharm_Classes>
Adrenergic alpha-Antagonists [MoA],alpha-Adrenergic Blocker [EPC]
</Pharm_Classes>
<DEASchedule/>
<Status>
Deprecated
</Status>
<LastUpdate>
2020-01-01
</LastUpdate>
<PackageNdcExcludeFlag/>
<ProductNdcExcludeFlag>
N
</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough>
20191231
</ListingRecordCertifiedThrough>
<StartMarketingDatePackage/>
<EndMarketingDatePackage/>
<SamplePackage/>
</NDC>